![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 20, Issue 22, 4720-4729, November 15, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104
Submitted June 8, 2009;
Revised September 1, 2009;
Accepted September 10, 2009
Monitoring Editor: Adam Linstedt
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Zerial and McBride, 2001; Grosshans et al., 2006). Rab5, in particular, is localized to early endosomes and plasma membrane and regulates early membrane fusion in the cell (Bucci et al., 1992; Li et al., 1994; Stenmark et al., 1994) as well as actin remodeling (Lanzetti et al., 2004). Like other GTPases, Rab5 alternates between guanosine diphosphate (GDP)-bound and guanosine triphosphate (GTP)-bound conformations, and it is the GTP-bound form that is biologically active and interacts with effectors. One of such effectors is early endosomal antigen (EEA) 1, which functions as a tethering factor to promote early endosome fusion in endocytosis (Simonsen et al., 1998; Christoforidis et al., 1999).
Rab5 activation, i.e., Rab5-GDP to Rab5-GTP conversion, requires guanine nucleotide exchange factors (GEFs) that facilitate GDP dissociation and GTP loading. Rabex-5 is a well-documented Rab5 GEF (Horiuchi et al., 1997; Lippe et al., 2001). Rabex-5 knockout mice develop severe skin inflammation caused by enhanced immunoglobulin (Ig) E receptor-mediated degranulation and cytokine release from mast cells, which is due to loss of Rabex-5 GEF activity for Rab5 and reduced IgE receptor endocytosis/degradation (Kalesnikoff et al., 2007). Rabex-5 contains 492 amino acid residues, and the catalytic GEF domain resides in the middle region, encompassing residues 132-391 and consisting of a helical bundle (HB) domain and a Vps9 domain in tandem (Delprato et al., 2004). Rabex-5 contains no transmembrane domain but can target to early endosomal membrane for Rab5 activation by two mechanisms. An indirect mechanism is mediated by the Rabaptin-5-binding domain immediately downstream of the GEF domain, which leads to the formation of Rabex-5/Rabaptin-5 complexes (Lippe et al., 2001; Mattera et al., 2006; Delprato and Lambright, 2007; Kalesnikoff et al., 2007; Zhu et al., 2007). Rabaptin-5 is a Rab5 effector that binds to Rab5-GTP on early endosomes (Stenmark et al., 1995; Zhu et al., 2004) and brings Rabex-5 to the proximity of more substrates (Rab5-GDP) on the target membrane, which may lead to further Rab5 activation in a positive feedback loop. In addition, a direct membrane targeting mechanism is mediated by the early endosomal targeting (EET) domain that is composed of a membrane-binding motif immediately upstream of the GEF domain and the following HB domain, thus overlapping with the GEF domain (Zhu et al., 2007). The EET domain-mediated direct membrane targeting allows Rabex-5 to associate with early endosomes and activate Rab5 independent of Rabaptin-5, which may generate a relatively high basal level of Rab5-GTP on early endosomes to facilitate recruitment of Rabex-5/Rabaptin-5 complexes for further Rab5 activation and establishment of functional Rab5-GTP domains in endosome fusion. However, the nature of the EET domain binding site on early endosomes is yet to be determined. In addition, a recent study suggests that the N-terminal ubiquitin-binding regions also contribute to direct Rabex-5 targeting to early endosomes (Mattera and Bonifacino, 2008).
In the current study, we find that Rab22, in its GTP-bound form, serves as the early endosomal binding site for the EET domain of Rabex-5 and is responsible for direct Rabex-5 targeting to early endosomes. Rab22 is another Rab GTPase localized on early endosomes and is closely related to Rab5 with 52% sequence identity (Olkkonen et al., 1993; Kauppi et al., 2002). Inhibition of Rab22 function via small interfering RNA (siRNA) blocks recycling of endocytosed cargoes such as transferrin receptor and MHC-I (Weigert et al., 2004; Magadan et al., 2006). Overexpression of Rab22 in the cell leads to enlargement of early endosomes (Kauppi et al., 2002), similar to the effect of Rab5. Rab22 is a member of the Rab5 subfamily that also includes Rab5, Rab21, and Rab31 (also called Rab22b) (Pereira-Leal and Seabra, 2000; Stenmark and Olkkonen, 2001). Rabex-5 is specific for Rab5 and Rab21, whereas its GEF activity toward Rab22 and other Rabs decreases dramatically by two orders of magnitude or more (Delprato et al., 2004). Here, we find that in contrast to its interaction with GDP-bound form of Rab5, Rabex-5 binds to GTP-bound Rab22 and is thus an effector for Rab22. It is Rab22 that recruits Rabex-5 to early endosomes for Rab5 activation, establishing a Rab22-Rab5 signaling relay in regulation of early endosome fusion in the cell.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Mammalian Cell Cultures and Transfection
Baby hamster kidney (BHK)-21 cells were cultured as described previously (Zhu et al., 2007). The Rabex-5–deficient NF73 cells, which were mouse embryo fibroblasts isolated from Rabex-5 knockout mice (Kalesnikoff et al., 2007), were kindly provided by Dr. S. J. Galli's laboratory at Stanford University (Stanford, CA). NF73 and HeLa cells were grown in 35-mm culture dishes with 3 ml of DMEM containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA). Cells were transfected with the plasmid constructs expressing various Rabex-5, Rab22, and Rab5 proteins as indicated via FuGENE HD-mediated procedure (Roche Applied Science, Indianapolis, IN) and incubated at 37°C in a tissue culture incubator with 5% CO2. The expression vectors included pcDNA3 (Invitrogen), pBI (Clontech, Mountain View, CA), and pSIREN-RetroQ-DsRed-Express (Clontech). The pBI vector can express two cloned proteins simultaneously, whereas the pSIREN-RetroQ-DsRed-Express vector can express a cloned short hairpin RNA (shRNA) and dsRed simultaneously. Protein expression was confirmed by immunoblot analysis, and intracellular localization and endosomal morphology were determined by confocal fluorescence microscopy (see below).
Immunoblot Analysis
Cells were lysed in 1% SDS (200 µl/35-mm dish), and the lysates were sheared to reduce the stickiness by passing through a 26-gauge needle five times with a 1-ml syringe, followed by SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblot assays by using the enhanced chemiluminescence reagents (GE Healthcare, Chalfont St. Giles, Buckinghamshire, United Kingdom). The primary antibodies used in the immunoblot assays were anti-Myc and anti-actin monoclonal antibody (mAb) from Sigma-Aldrich (St. Louis, MO), anti-Rabex-5 mAb from BD Biosciences (San Jose, CA), and anti-Rab22 rabbit polyclonal antibody from Proteintech Group (Chicago, IL). The results were quantified by densitometry using Densitometer SI (GE Healthcare).
Confocal Fluorescence Microscopy
We used a Leica confocal laser scanning microscope with Ar-488 and Kr-568 laser excitation in the Flow and Image laboratory on campus. BHK-21, HeLa, and NF73 cells were grown on coverslips with or without transfection. The plasmids used for transfection included pBI and pcDNA3 constructs expressing various green fluorescent protein (GFP)-Rabex-5, red fluorescent protein (RFP)-Rab22, and GFP-Rab5 proteins, and the pSIREN-RetroQ-DsRed-Express constructs expressing Rab22 shRNAs as indicated. Cells were incubated at 37°C for 24 or 48 h as indicated and then processed for confocal fluorescence microscopy to determine the morphology of endogenous or GFP-Rabex-5–, RFP-Rab22–, and GFP-Rab5–labeled early endosomes in the cells. In this case, cells were rinsed three times with phosphate-buffered saline (PBS) and fixed for 20 min with 4% paraformaldehyde (w/v in PBS) at room temperature. The coverslips were then directly processed for microscopy or used for further immunofluorescence microscopy to identify endogenous Rab5, Rabex-5, Rab22, and EEA1. In this case, the fixed cells were permeabilized with 0.1% saponin or Triton X-100 (w/v in PBS), and probed with the anti-Rab5, anti-Rabex-5, anti-Rab22, and anti-EEA1 antibodies from BD Biosciences, Proteintech Group, and Santa Cruz Biotechnology (Santa Cruz, CA), respectively. The secondary antibodies were goat anti-mouse IgG conjugated to Alexa568 (red) and goat anti-rabbit IgG conjugated to Alexa488 (green) or Alexa647 (blue) (Invitrogen). The coverslips were then mounted in PBS on glass slides and viewed with a microscope.
Glutathione Transferase (GST) Pull-Down Assay
We cloned the cDNAs of Rab5 and Rab22 into the pGEX-4T-2 vector (GE Healthcare) and the resulting pGEX-4T-2/Rab5 and pGEX-4T-2/Rab22 constructs were then used to transform the Escherichia coli strain DH5
and to express GST-Rab5 and GST-Rab22 fusion proteins, respectively. GST-Rab5 and GST-Rab22 were then affinity purified with glutathione-Sepharose 4B resin (GE Healthcare) and loaded with guanosine 5'-O-(3-thio)triphosphate (GTP
S) or guanosine 5'-O-(2-thio)diphosphate (GDPβS) (Sigma-Aldrich) for the pull-down assays with various Rabex-5 proteins. Each Rabex-5 protein contained a Myc epitope at the N terminus and was expressed via the pBI vector in BHK cells for 24 h at 37°C. The cells were then washed with ice-cold PBS and lysed for 5 min in the lysis buffer, which contained 25 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 0.1% NP-40, 10% glycerol, 1 mM dithiothreitol, and protease inhibitor cocktail (Sigma-Aldrich). Lysates were clarified by centrifugation at 10,000 x g for 2 min at 4°C, and the supernatants (180 µl) were incubated with 20 µl (20 µg) of the GST-Rab5 or GST-Rab22 fusion proteins on the glutathione-Sepharose 4B resin for 30 min at 4°C on a rotating mixer. The resin was subsequently rinsed with the lysis buffer, resuspended in SDS sample buffer, boiled for 3 min, and subjected to SDS-PAGE (12% gel), followed by immunoblot analysis with the anti-Myc antibody.
Epidermal Growth Factor (EGF) Endocytosis and Degradation
NF73 cells were grown on glass coverslips in 35-mm culture dishes and transfected with peGFP-N1/EGFR and pBI constructs expressing various Myc-tagged Rabex-5 proteins, respectively, for 24 h. Then the growth medium was replaced with a HEPES-buffered medium containing Alexa555-EGF (5 ng/ml) (Invitrogen) and bovine serum albumin (2 mg/ml) and incubated for 10 min at 37°C. Cells were then washed four times with the HEPES-buffered medium without Alexa555-EGF and chased in the same medium for 0, 0.5, 2, and 4 h at 37°C. The cells were rinsed, fixed, and processed for confocal immunofluorescence microscopy as described above. In this case, the immunofluorescence staining was to confirm the expression of Myc-tagged Rabex-5 proteins with an anti-Myc mAb and a secondary goat anti-mouse IgG conjugated to Alexa647. The fluorescence of epidermal growth factor receptor (EGFR)-enhanced (e)GFP and Alexa555-EGF was directly observed in the same cells. The total fluorescence intensity of Alexa555-EGF in the cell was quantified with 60 randomly selected cells that also contained EGFR-eGFP and the indicated Myc-Rabex-5 construct in each experiment. The SEM was obtained from three independent experiments.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
S or GDPβS and used to pull-down various Rabex-5 constructs expressed in BHK cells. The Rabex-5 constructs included the full-length protein (FL, residues 1-492), the GEF domain (residues 135-399), and the EET domain (residues 81-230), and each contained an N-terminal myc epitope for immunoblot detection (Figure 1A). Rab5 loaded with GDPβS but not GTPS was associated with the GEF domain (Figure 1B), in support of its high GEF activity toward Rab5 (Delprato et al., 2004). Full-length Rabex-5 showed no detectable binding to Rab5 (Figure 1B), consistent with the fact that it has little GEF activity toward Rab5 in vitro due to a block by the coiled-coil domain immediately downstream of the GEF domain (Delprato and Lambright, 2007; Zhu et al., 2007). In contrast, full-length Rabex-5 effectively associated with Rab22 and only with its GTPS-loaded form (Figure 1B). The binding of Rabex-5 to Rab22-GTP seemed much stronger than the binding of the GEF domain to Rab5-GDP, based on the ratio of pull-down signal over input (compare Figure 1A with Figure 1B). Importantly, the Rabex-5 and Rab22 interaction was mediated by the EET domain, which was bound to Rab22-GTPS, like the full-length protein (Figure 1B). Because the EET domain is essential for direct membrane targeting of Rabex-5 to early endosomes (Zhu et al., 2007), the data suggest that Rab22 may recruit Rabex-5 to the early endosomes. We also included Rab21 and Rab31 in these pull-down assays. Rab21 interacted with Rabex-5 in the same manner as Rab5, whereas Rab31 was not associated with any of the Rabex-5 constructs tested (data not shown).
|
S or GDPβS (Figure 2B). The results showed that GST-Rab22 efficiently pulled down Rabex-5(81-399) as well as associated Rab5:S34N in a GTPS-dependent manner (Figure 2B), suggesting formation of a tripartite complex of Rabex-5(81-399) and the two Rabs. The nucleotide-dependence of pull-down signals suggested specific protein interactions between Rab22 and Rabex-5(81-399)/Rab5:S34N rather than nonspecific binding to glutathione-Sepharose resin or GST.
|
), showed the same colocalization with RFP-Rab22, but these endosomes were much smaller and tended to cluster together (Figure 3). The clustered small endosomes were likely due to competition of the mutant with endogenous Rabex-5 for interaction with Rab22 and Rab5, leading to inhibition of endosome fusion. Moreover, GFP-Rabex-5(81-230), i.e., the EET domain, was sufficient for targeting to the RFP-Rab22–containing early endosomes in the cell (Figure 3), consistent with the pull-down data (Figure 1) and supporting our contention that Rab22 binds to the EET domain of Rabex-5 to recruit Rabex-5 to the membrane. In contrast, GFP-Rabex-5(135-399), i.e., the GEF domain, exhibited diffused cytosolic staining throughout the cell, and there was no colocalization with RFP-Rab22 and EEA1 on the early endosomes (Figure 3). Taken together, the data suggest that Rab22 may recruit Rabex-5 to the early endosomal membrane where Rabex-5 subsequently activates Rab5 to promote fusion and enlargement of these endosomes.
|
) was used in this study and expressed in HeLa cells via the pSIREN-RetroQ-DsRed-Express vector, which simultaneously expressed dsRed-Express, an RFP, for identification of transfected cells by fluorescence microscopy. The effective knock down of Rab22 expression in the cell was confirmed by immunofluorescence microscopy with an anti-Rab22 antibody. Endogenous Rab22 showed punctate endosomal staining in the cytoplasm (Figure 4A), as reported previously (Weigert et al., 2004; Magadan et al., 2006). The Rab22 signal was dramatically reduced in transfected cells that expressed the Rab22-specific shRNA, which were identified by the red fluorescence in these cells (Figure 4A). As a negative control, expression of a scrambled shRNA had no effect on the Rab22 level in the cell (Figure 4A). Further immunoblot analysis of the cell lysates confirmed the effectiveness of the Rab22-specific shRNA, which reduced the Rab22 level by more than 80% in these cells (Figure 4B).
|
). In contrast, cells that coexpressed the Rab22-specific shRNA with GFP-Rabex-5, as identified by the presence of both red and green fluorescence in the same cell, showed dramatic reduction in early endosome-associated GFP-Rabex-5, which instead was redistributed to the cytosol as evidenced by the diffuse green fluorescence throughout the cytoplasm (Figure 4C). Residual GFP-Rabex-5 could also be found on some small EEA1-containing endosomes (Figure 4C, arrows), which were not significantly enlarged, reflecting reduced recruitment of GFP-Rabex-5 on the membrane. In control cells that expressed a scrambled shRNA, GFP-Rabex-5 targeted normally to early endosomes and enlarged these endosomes (Figure 4C), like in the cells expressing GFP-Rabex-5 alone (Figure 4C).
The data showed that targeting of GFP-Rabex-5 to early endosomes was dependent on Rab22. Although Rabaptin-5 in Rab22-depleted cells could potentially bind to GFP-Rabex-5 and recruit it to the endosomes, endogenous Rabaptin-5 is limiting and already associated with endogenous Rabex-5 and thus unavailable to form new complexes with GFP-Rabex-5 (Zhu et al., 2007). In support of this contention, coexpression of Rabaptin-5 with GFP-Rabex-5 was able to rescue the defective membrane targeting of GFP-Rabex-5 in Rab22-depleted cells (Supplemental Figure S1).
Rabex-5 Mediates Functional Synergy of Rab22 and Rab5 in Regulation of Early Endosomal Dynamics
To determine how Rab22-mediated recruitment of Rabex-5 may impact Rab5 activation and early endosomal dynamics, we first examined, via confocal immunofluorescence microscopy, if endogenous Rab22 and Rab5 colocalize on early endosomes in BHK and NF73 cells. The latter was a Rabex-5–deficient mouse embryo fibroblast line isolated from Rabex-5 knockout mice (Kalesnikoff et al., 2007). In both cell types, Rab22 and Rab5 colocalized to punctate early endosomes (Figure 5A, arrows). However, the Rab5 staining on early endosomes in NF73 cells was consistently weaker, especially considering its much higher expression level in NF73 cells than in BHK cells (Figure 5B). NF73 cells might up-regulate Rab5 expression to compensate for the loss of Rabex-5. Alternatively, Rabex-5 as a ubiquitin ligase (Mattera et al., 2006) could target Rab5 for degradation, leading to lower steady-state level of Rab5 in normal cells. Another interesting observation was that the Rab22- and Rab5-containing early endosomes clustered at the perinuclear region in BHK cells, whereas they were evenly distributed throughout the cytoplasm in NF73 cells (Figure 5A). Both BHK and NF73 are fibroblasts with elongated morphology, in contrast to HeLa cells. The redistribution of early endosomes in NF73 cells seems to be due to Rabex-5 deficiency and reduced Rab5 activity, because expression of Rabex-5 in NF73 cells restored the perinuclear localization pattern of Rab5 and Rab22 (Figure 5A). The data are consistent with a role of Rab5 in regulation of early endosomal movement along the cytoskeleton (Nielsen et al., 1999).
|
). Our data can be reconciled if Rabex-5 competes with EEA1 for binding to Rab22-GTP on the early endosomes in normal cells, suppressing Rab22-mediated endosome fusion while activating Rab5-mediated endosome fusion. Introduction of Rabex-5 into NF73 cells completely restored the colocalization of GFP-Rab5 and RFP-Rab22 on enlarged early endosomes (Figure 5C). Like Rabex-5, Rabex-5(1-399) and Rabex-5(135-480) were also able to restore the colocalization of GFP-Rab5 and RFP-Rab22 on enlarged endosomes in NF73 cells (Supplemental Figure S2). Rabex-5(135-480) lacks the Rab22-binding domain, but it can target to early endosomes indirectly via association with Rabaptin-5 in NF73 cells. Expression of Rabex-5:D314A, a mutant without Rab5 GEF activity, inhibited early endosome fusion and resulted in colocalization of GFP-Rab5 and RFP-Rab22 in clustered small endosomes (Supplemental Figure S2). The data suggest that Rab5 and Rab22 target to the same early endosomes and Rabex-5 plays a key role in maintaining their colocalization in the cell. In the absence of Rabex-5, increased Rab22-mediated membrane fusion, without accompanied increase in Rab5-mediated fusion, may contribute to the separation of the two Rabs into different populations of endosomes.
The function of the Rab22-Rabex-5-Rab5 cascade was further examined by determining endocytosis and degradation of EGF in the Rabex-5–deficient NF73 cells. The uptake of Alexa555-EGF was monitored by confocal fluorescence microscopy. To facilitate EGF endocytosis, NF73 cells were transfected with a construct expressing EGFR-GFP and the transfected cells showed strong uptake of Alexa555-EGF that colocalized with EGFR-GFP in punctate endosomes (data not shown). To determine the kinetics of Alexa555-EGF degradation, an initial 10-min uptake was followed by different times of chase in fresh medium without Alexa555-EGF. It was apparent that the degradation kinetics was very slow in these cells (Figure 6). Immediately after the uptake, Alexa555-EGF showed up in puncate endosomes in all cells containing EGFR-GFP. The total fluorescence intensity of Alexa55-EGF in the cell gradually decreased over time due to degradation in late endosomes/lysosomes (Figure 6). However, there were still 50% of Alexa555-EGF retained in the cell after a 4-h chase (Figure 6). In comparison, coexpression of Rabex-5 in these cells greatly accelerated Alexa555-EGF degradation, with nearly 80 and 90% degradation achieved within 2 and 4 h, respectively (Figure 6). At these times, the Alexa555-EGF fluorescence signal was dramatically reduced and was beyond detection in most cells. The Rabex-5–facilitated EGF degradation was mediated by its activation of Rab5, because the Rabex-5:D314A mutant lacking Rab5 GEF activity failed to increase Alexa555-EGF degradation (Figure 6).
|
). To distinguish the two Rabex-5 pathways, we took advantage of the two Rabex-5 constructs: Rabex-5(1-399) and Rabex-5(135-480) that can use the direct and indirect pathways, respectively (Zhu et al., 2007). Rabex-5(1-399) contains the EET domain for binding to Rab22 and targets to early endosomes directly, but lacks the Rabaptin-5–binding domain. In contrast, Rabex-5(135-480) contains the Rabaptin-5-binding domain, but lacks the EET domain. Expression of Rabex-5(1-399), like Rabex-5, strongly increased Alexa555-EGF degradation in the cell (Figure 6). Rabex-5(135-492) was also able to increase Alexa555-EGF degradation, but the kinetics was much slower (Figure 6). The data suggest that the Rab22–Rabex-5–Rab5 cascade is functionally important in promoting a faster and efficient endocytic pathway for ligand/receptor degradation, e.g., EGF and EGFR. |
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Zhu et al., 2004). In this case, Rabex-5 forms a complex with Rabaptin-5 and the complex targets to early endosomes via Rabaptin-5 binding to Rab5-GTP on the membrane (Lippe et al., 2001). Here, we identify a novel membrane targeting pathway that directly recruits Rabex-5 to early endosomes via binding to Rab22-GTP on the early endosomes.
Our finding that Rabex-5 differentially interacts with Rab5 and Rab22 is consistent with previous observations that Rabex-5 shows strong GEF activity toward Rab5 but not Rab22 (Delprato et al., 2004). Indeed, our pull-down results indicate that Rabex-5 interacts with GDP-bound but not GTP-bound Rab5. In contrast, Rabex-5 binds to GTP-bound Rab22, establishing Rabex-5 as a Rab22 effector. Rabex-5 binds Rab22 via its EET domain (residues 81-230), which is immediately upstream of the catalytic Vps9 domain (residues 231-400). Interestingly, Rabex-5 binds to Rabaptin-5 via a coiled-coil domain (residues 401-462) immediately downstream of the Vps9 domain (Mattera et al., 2006; Delprato and Lambright, 2007; Kalesnikoff et al., 2007; Zhu et al., 2007). Thus, Rabex-5 targets to the early endosomes directly or indirectly via two domains flanking the catalytic Vps9 domain that acts on Rab5-GDP and stimulates its GDP dissociation and GTP loading.
Rab22-GTP recruits Rabex-5 to the membrane, which in turn acts on Rab5-GDP to convert it to Rab5-GTP. This Rab22-Rab5 signaling pathway represents a new Rab GTPase cascade in the regulation of early endosomal dynamics. In mammalian cells, the Rab5 subfamily of Rab GTPases contains four highly related members including Rab5, Rab21, Rab22, and Rab31 (also called. Rab22b) (Pereira-Leal and Seabra, 2000; Stenmark and Olkkonen, 2001). Three of them, Rab5, Rab21, and Rab22, reside in the early endosomes. Like Rab5, Rab21 seems to promote early endosome fusion and receptor-mediated endocytosis (Simpson et al., 2004). Importantly, Rab21 is as a good substrate as Rab5 for the GEF activity of Rabex-5 (Delprato et al., 2004). Thus, the Rab22-Rab5 cascade should include Rab21 and the recruitment of Rabex-5 by Rab22-GTP may lead to activation of both Rab5 and Rab21, suggesting a temporal convergence of functional Rab domains on the early endosomal membrane. Our data show that Rabex-5 is necessary for functional coupling of Rab22 and Rab5 in early endosome fusion. Endogenous Rab22 and Rab5 activities are limited, as evidenced by punctate small early endosomal structures in normal cells, and coexpression of Rab22 and Rab5 leads to synergistic enlargement of the early endosomes. However, this functional synergy is lost in Rabex-5-deficient NF73 cells. In this case, expression of Rab22 alone dramatically enlarges the endosomes, whereas expression of Rab5 has little effect, Thus, although Rabex-5 activates Rab5 as a GEF, it inhibits Rab22 as an effector at the same time in endosome fusion, presumably by competing with EEA1 for binding to Rab22-GTP on the endosomal membrane. Our data suggest that Rab22- and Rab5-mediated endosome fusions are functionally distinct in early endosomal sorting and Rabex-5 level in the cell determines which type of fusion and sorting prevails. The Rab22–Rabex-5–Rab5 cascade promotes Rab5-mediated endosome fusion, which in turn promotes endocytic traffic and degradation of encytosed ligands, e.g., EGF.
The identification of Rab22-Rabex-5-Rab5 signaling cascade supports a general concept of Rab cascade in regulation of intracellular membrane trafficking. The first Rab-GEF-Rab cascade was identified in the yeast exocytic pathway where two homologous Rabs Ypt31 and Ypt32p, in the GTP-bound form, recruit Sec2p to the Golgi membrane (Ortiz et al., 2002). Sec2p is a GEF for the downstream Rab Sec4p that promotes transport of Golgi-derived vesicles to the plasma membrane (Walch-Solimena et al., 1997); thus, Sec2p activates Sec4p and functionally links Ypt31p/32p and Sec4p to promote exocytosis (Ortiz et al., 2002). A variation on the theme is the TRAnsport Protein Particle complex that switches its GEF specificity from Ypt1 to Ypt31 via incorporation of additional subunits (Morozova et al., 2006). In mammalian systems, the Rab5-Rab7 conversion that occurs during the transition from early endosomes to late endosomes is suggested to involve a Rab cascade mediated by two components of the class C VPS/HOPS complex, Vps11p and Vps39p (Rink et al., 2005). Vps11p is a Rab5 effector, whereas Vps39p contains GEF activity for Ypt7 (Wurmser et al., 2000) and is assumed to contain GEF activity for its mammalian homolog Rab7. This assumption, however, remains to be established. Our current study identifies a Rab22–Rabex-5–Rab5 signaling cascade within the early endosomal network and suggests another layer of complexity in the regulation of early endosomal dynamics.
The Rab22-mediated recruitment of Rabex-5 to early endosomes is distinct from the ubiquitin-mediated Rabex-5 recruitment reported recently (Mattera and Bonifacino, 2008), because the EET domain, in the absence of N-terminal ZnF and MIU domains, is necessary and sufficient for binding to Rab22-GTP and targeting to Rab22-containing early endosomes. The relationship of the two membrane targeting pathways is unclear at present, but they are not mutually exclusive and both may contribute to the association of Rabex-5 with early endosomes. Direct targeting of Rabex-5 to early endosomes activates Rab5, which in turn recruits Rabaptin-5/Rabex-5 complexes that further activates Rab5 and produces more Rab5-GTP to maintain the Rab5 domain (Horiuchi et al., 1997; Lippe et al., 2001). With the identification of Rabex-5 as a Rab22 effector, a new Rab GTPase cascade emerges within the early endosomal network that begins with Rab22-mediated activation of Rab5 and/or Rab21, which is then followed by linkage to Rab7 for further trafficking along the endocytic pathway (Rink et al., 2005).
|
ACKNOWLEDGMENTS |
|---|
|
Footnotes |
|---|
Address correspondence to: Guangpu Li (guangpu-li{at}ouhsc.edu)
Abbreviations used: BHK, baby hamster kidney; EET, early endosomal targeting; EGF, epidermal growth factor; FL, full length; GEF, guanine nucleotide exchange factor; GFP, green fluorescent protein; GST, glutathione transferase; HB, helical bundle; RFP, red fluorescent protein; WT, wild type.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Christoforidis, S., McBride, H. M., Burgoyne, R. D., and Zerial, M. (1999). The Rab5 effector EEA1 is a core component of endosome docking. Nature 397, 621–625.[CrossRef][Medline]
Delprato, A., and Lambright, D. G. (2007). Structural basis for Rab GTPase activation by VPS9 domain exchange factors. Nat. Struct. Mol. Biol 14, 406–412.[CrossRef][Medline]
Delprato, A., Merithew, E., and Lambright, D. G. (2004). Structure, exchange determinants, and family-wide rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5. Cell 118, 607–617.[CrossRef][Medline]
Grosshans, B. L., Ortiz, D., and Novick, P. (2006). Rabs and their effectors: achieving specificity in membrane traffic. Proc. Natl. Acad. Sci. USA 103, 11821–11827.
Horiuchi, H. et al. (1997). A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell 90, 1149–1159.[CrossRef][Medline]
Kalesnikoff, J., Rios, E. J., Chen, C. C., Alejandro Barbieri, M., Tsai, M., Tam, S. Y., and Galli, S. J. (2007). Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cells. Blood 109, 5308–5317.
Kauppi, M., Simonsen, A., Bremnes, B., Vieira, A., Callaghan, J., Stenmark, H., and Olkkonen, V. M. (2002). The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking. J. Cell Sci 115, 899–911.
Lanzetti, L., Palamidessi, A., Areces, L., Scita, G., and Di Fiore, P. P. (2004). Rab5 is a signalling GTPase involved in actin remodelling by receptor tyrosine kinases. Nature 429, 309–314.[CrossRef][Medline]
Li, G., Barbieri, M. A., Colombo, M. I., and Stahl, P. D. (1994). Structural features of the GTP-binding defective Rab5 mutants required for their inhibitory activity on endocytosis. J. Biol. Chem 269, 14631–14635.
Lippe, R., Miaczynska, M., Rybin, V., Runge, A., and Zerial, M. (2001). Functional synergy between Rab5 effector Rabaptin-5 and exchange factor Rabex-5 when physically associated in a complex. Mol. Biol. Cell 12, 2219–2228.
Magadan, J. G., Barbieri, M. A., Mesa, R., Stahl, P. D., and Mayorga, L. S. (2006). Rab22a regulates the sorting of transferrin to recycling endosomes. Mol. Cell. Biol 26, 2595–2614.
Mattera, R., and Bonifacino, J. S. (2008). Ubiquitin binding and conjugation regulate the recruitment of Rabex-5 to early endosomes. EMBO J 27, 2484–2494.[CrossRef][Medline]
Mattera, R., Tsai, Y. C., Weissman, A. M., and Bonifacino, J. S. (2006). The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J. Biol. Chem 281, 6874–6883.
Morozova, N., Liang, Y., Tokarev, A. A., Chen, S. H., Cox, R., Andrejic, J., Lipatova, Z., Sciorra, V. A., Emr, S. D., and Segev, N. (2006). TRAPPII subunits are required or the specificity switch of a Ypt-Rab GEF. Nat. Cell Biol 8, 1263–1269.[CrossRef][Medline]
Nielsen, E., Severin, F., Backer, J. M., Hyman, A. A., and Zerial, M. (1999). Rab5 regulates motility of early endosomes on microtubules. Nat. Cell Biol 1, 376–382.[CrossRef][Medline]
Olkkonen, V. M., Dupree, P., Killisch, I., Lutcke, A., Zerial, M., and Simons, K. (1993). Molecular cloning and subcellular localization of three GTP-binding proteins of the rab subfamily. J. Cell Sci 106, 1249–1261.[Abstract]
Ortiz, D., Medkova, M., Walch-Solimena, C., and Novick, P. (2002). Ypt32 recruits the Sec4p guanine nucleotide exchange factor, Sec2p, to secretory vesicles; evidence for a Rab cascade in yeast. J. Cell Biol 157, 1005–1015.
Pereira-Leal, J. B., and Seabra, M. C. (2000). The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily. J. Mol. Biol 301, 1077–1087.[CrossRef][Medline]
Rink, J., Ghigo, E., Kalaidzidis, Y., and Zerial, M. (2005). Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735–749.[CrossRef][Medline]
Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J. M., Brech, A., Callaghan, J., Toh, B. H., Murphy, C., Zerial, M., and Stenmark, H. (1998). EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 394, 494–498.[CrossRef][Medline]
Simpson, J. C., Griffiths, G., Wessling-Resnick, M., Fransen, J. A., Bennett, H., and Jones, A. T. (2004). A role for the small GTPase Rab21 in the early endocytic pathway. J. Cell Sci 117, 6297–6311.
Stenmark, H., and Olkkonen, V. M. (2001). The Rab GTPase family. Genome Biol 2, REVIEWS3007.[Medline]
Stenmark, H., Parton, R. G., Steele-Mortimer, O., Lutcke, A., Gruenberg, J., and Zerial, M. (1994). Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 13, 1287–1296.[Medline]
Stenmark, H., Vitale, G., Ullrich, O., and Zerial, M. (1995). Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell 83, 423–432.[CrossRef][Medline]
Walch-Solimena, C., Collins, R. N., and Novick, P. J. (1997). Sec2p mediates nucleotide exchange on Sec4p and is involved in polarized delivery of post-Golgi vesicles. J. Cell Biol 137, 1495–1509.
Weigert, R., Yeung, A. C., Li, J., and Donaldson, J. G. (2004). Rab22a regulates the recycling of membrane proteins internalized independently of clathrin. Mol. Biol. Cell 15, 3758–3770.
Wurmser, A. E., Sato, T. K., and Emr, S. D. (2000). New component of the vacuolar class C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNARE-dependent docking and fusion. J. Cell Biol 151, 551–562.
Zerial, M., and McBride, H. (2001). Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol 2, 107–117.[CrossRef][Medline]
Zhu, G., Zhai, P., Liu, J., Terzyan, S., Li, G., and Zhang, X. C. (2004). Structural basis of Rab5-Rabaptin5 interaction in endocytosis. Nat. Struct. Mol. Biol 11, 975–983.[CrossRef][Medline]
Zhu, H., Zhu, G., Liu, J., Liang, Z., Zhang, X. C., and Li, G. (2007). Rabaptin-5-independent membrane targeting and Rab5 activation by Rabex-5 in the Cell. Mol. Biol. Cell 18, 4119–4128.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 cells were measured and shown are the mean and calculated SEM.